Strengths and Limitations of Using the Polypill in Cardiovascular Prevention

被引:44
作者
Roy, Ambuj [1 ]
Naik, Nitish [1 ]
Reddy, K. Srinath [2 ]
机构
[1] Publ Hlth Fdn India, New Delhi, India
[2] Publ Hlth Fdn India, Inst Area, Plot 47,Sect 44, Gurugram 122002, India
关键词
Polypill; Fixed dose combination; Cardiovascular diseases; Adherence; Secondary prevention; Primary prevention; LOW-INCOME COUNTRIES; ALL-CAUSE MORTALITY; HIGH-RISK; BLOOD-PRESSURE; MIDDLE-INCOME; DISEASE; ADHERENCE; STRATEGY; INDIVIDUALS; CHOLESTEROL;
D O I
10.1007/s11886-017-0853-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Polypill and its role in cardiovascular disease (CVD) prevention has been extensively discussed and debated since the inception of the concept in 2003. This article reviews the subsequent accumulated research in this area. Recent Findings Several short and intermediate to long-term studies with different brands of polypills have analysed the impact of polypill in phase II and III trials. The strengths of polypill that have emerged include better adherence, equivalent or better risk factor control and quality of life among polypill users as compared to usual care. The lurking limitations include difficulty with dose adjustment to targets, fear of mass medicalisation and low acceptability among physicians. Summary The current literature supports polypill use in reducing blood pressure and cholesterol levels for CVD prevention with improvement in adherence to medication. However, the long-term outcome of polypill on CVD events and mortality are unavailable and are currently being studied in clinical trials.
引用
收藏
页数:8
相关论文
共 30 条
[1]   Polypill Therapy, Subclinical Atherosclerosis, and Cardiovascular Events-Implications for the Use of Preventive Pharmacotherapy [J].
Bittencourt, Marcio Sommer ;
Blaha, Michael J. ;
Blankstein, Ron ;
Budoff, Matthew ;
Vargas, Jose D. ;
Blumenthal, Roger S. ;
Agatston, Arthur S. ;
Nasir, Khurram .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (05) :434-443
[2]   The polypill: An effective approach to increasing adherence and reducing cardiovascular event risk [J].
Bramlage, Peter ;
Sims, Helen ;
Minguet, Joan ;
Ferrero, Carmen .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (03) :297-310
[3]   A Polypill Strategy to Improve Adherence Results From the FOCUS Project [J].
Castellano, Jose M. ;
Sanz, Gines ;
Penalvo, Jose L. ;
Bansilal, Sameer ;
Fernandez-Ortiz, Antonio ;
Alvarez, Luz ;
Guzman, Luis ;
Carlos Linares, Juan ;
Garcia, Fernando ;
D'Aniello, Fabiana ;
Albert Arnaiz, Joan ;
Varea, Sara ;
Martinez, Felipe ;
Lorenzatti, Alberto ;
Imaz, Inaki ;
Sanchez-Gomez, Luis M. ;
Carla Roncaglioni, Maria ;
Baviera, Marta ;
Smith, Sidney C., Jr. ;
Taubert, Kathryn ;
Pocock, Stuart ;
Brotons, Carlos ;
Farkouh, Michael E. ;
Fuster, Valentin .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (20) :2071-2082
[4]   Fixed-dose combination therapy for the prevention of cardiovascular disease [J].
de Cates, Angharad N. ;
Farr, Matthew R. B. ;
Wright, Nicola ;
Jarvis, Morag C. ;
Rees, Karen ;
Ebrahim, Shah ;
Huffman, Mark D. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (04)
[5]   Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis [J].
Hippisley-Cox, J ;
Coupland, C .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7499) :1059-1063
[6]   The Polypill: From Promise to Pragmatism [J].
Huffman, Mark D. .
PLOS MEDICINE, 2015, 12 (08)
[7]   Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Kernan, Walter N. ;
Ovbiagele, Bruce ;
Black, Henry R. ;
Bravata, Dawn M. ;
Chimowitz, Marc I. ;
Ezekowitz, Michael D. ;
Fang, Margaret C. ;
Fisher, Marc ;
Furie, Karen L. ;
Heck, Donald V. ;
Johnston, S. Claiborne ;
Kasner, Scott E. ;
Kittner, Steven J. ;
Mitchell, Pamela H. ;
Rich, Michael W. ;
Richardson, DeJuran ;
Schwamm, Lee H. ;
Wilson, John A. .
STROKE, 2014, 45 (07) :2160-2236
[8]   Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data [J].
Khatib, Rasha ;
Mckee, Martin ;
Shannon, Harry ;
Chow, Clara ;
Rangarajan, Sumathy ;
Teo, Koon ;
Wei, Li ;
Mony, Prem ;
Mohan, Viswanathan ;
Gupta, Rajeev ;
Kumar, Rajesh ;
Vijayakumar, Krishnapillai ;
Lear, Scott A. ;
Diaz, Rafael ;
Avezum, Alvaro ;
Lopez-Jaramillo, Patricio ;
Lanas, Fernando ;
Yusoff, Khalid ;
Ismail, Noorhassim ;
Kazmi, Khawar ;
Rahman, Omar ;
Rosengren, Annika ;
Monsef, Nahed ;
Kelishadi, Roya ;
Kruger, Annamarie ;
Puoane, Thandi ;
Szuba, Andrzej ;
Chifamba, Jephat ;
Temizhan, Ahmet ;
Dagenais, Gilles ;
Gafni, Amiram ;
Yusuf, Salim .
LANCET, 2016, 387 (10013) :61-69
[9]   Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial [J].
Lafeber, M. ;
Grobbee, D. E. ;
Schrover, I. M. ;
Thom, S. ;
Webster, R. ;
Rodgers, A. ;
Visseren, F. L. J. ;
Bots, M. L. ;
Spiering, W. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 :193-199
[10]   Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease [J].
Lonn, Eva M. ;
Bosch, Jackie ;
Lopez-Jaramillo, Patricio ;
Zhu, Jun ;
Liu, Lisheng ;
Pais, Prem ;
Diaz, Rafael ;
Xavier, Denis ;
Sliwa, Karen ;
Dans, Antonio ;
Avezum, Alvaro ;
Piegas, Leopoldo S. ;
Keltai, Katalin ;
Keltai, Matyas ;
Chazova, Irina ;
Peters, Ron J. G. ;
Held, Claes ;
Yusoff, Khalid ;
Lewis, Basil S. ;
Jansky, Petr ;
Parkhomenko, Alexander ;
Khunti, Kamlesh ;
Toff, William D. ;
Reid, Christopher M. ;
Varigos, John ;
Leiter, Lawrence A. ;
Molina, Dora I. ;
McKelvie, Robert ;
Pogue, Janice ;
Wilkinson, Joanne ;
Jung, Hyejung ;
Dagenais, Gilles ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (21) :2009-2020